9d
Hosted on MSNBattling bladder cancer: New gene therapy to the rescueThe American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with almost 17,000 ...
Neuroblastoma is a solid tumor that occurs in children. When high-risk, the disease has a poor prognosis. Decades ago, adding ...
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
PRGN-2012—which Precigen has begun to call by its generic name of zopapogene imadenovec—is a gene therapy designed to elicit immune responses directed against cells infected with human papillomavirus ...
Trial at the Johns Hopkins Kimmel Cancer Center and other centers finds reduced-intensity haploidentical bone marrow ...
These successes provide valuable insights for developing treatments for other retinal conditions. The extraordinary potential of gene therapy brings important discussions about healthcare ...
The PORTOS assay could indicate when or when not to offer dose-escalated radiation for localized prostate cancer.
An 18-year survivor of neuroblastoma, a solid childhood tumor that develops in immature nerve cells, is believed to represent ...
The pioneering gene therapy developer will be acquired by investment firms Carlyle Group and SK Capital for a fraction of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results